Wall Street is finding an unexpected beneficiary of America's weight-loss boom: airlines. With the first GLP-1 weight-loss drug now available in pill form, analysts at Jefferies say broad adoption across society could quietly lower fuel bills — airlines' single largest cost — and lift earnings for…
Continue reading...